NIH R01 · 2024
PROJECT SUMMARY In the first half of 2020, the SARS-CoV-2 (COVID-19) pandemic infected nearly 4 million persons in the U.S. and caused over 150,000 deaths. In the midst of the early phase of this pandemic, people with multiple chronic conditions (MCC) including diabetes, hypertension, obesity, and dyslipidemia, which are increasingly common with age, were left extremely vulnerable to disruptions in healthcare delivery; in New York City (NYC), the first U.S. epicenter of the COVID-19 outbreak, traditional ambulatory care ceased entirely for several months and then reopened at only limited capacity. Implementation of telemedicine and modified in-person visits to bridge this gap was attempted…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.